Your browser doesn't support javascript.
loading
Identification of natural compound garcinone E as a novel autophagic flux inhibitor with anticancer effect in nasopharyngeal carcinoma cells.
Wei, Dan; Wang, Luolin; Lei, Shunmei; Zhang, Han; Dong, Caihua; Ke, Yao; Su, Yuting; Chen, Xiaoying; Xia, Lianping; Kong, Xiaoyang; Yin, Fuqiang; Liu, Xia.
Afiliação
  • Wei D; Key Laboratory of Longevity and Ageing-Related Disease of Chinese Ministry of Education, Center for Translational Medicine and School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi, P.R. China.
  • Wang L; Department of Gastroenterology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, P.R. China.
  • Lei S; Key Laboratory of Longevity and Ageing-Related Disease of Chinese Ministry of Education, Center for Translational Medicine and School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi, P.R. China.
  • Zhang H; Key Laboratory of Longevity and Ageing-Related Disease of Chinese Ministry of Education, Center for Translational Medicine and School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi, P.R. China.
  • Dong C; Key Laboratory of Longevity and Ageing-Related Disease of Chinese Ministry of Education, Center for Translational Medicine and School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi, P.R. China.
  • Ke Y; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Key Laboratory of Regenerative Medicine, Nanning, Guangxi, P.R. China.
  • Su Y; Department of Human Anatomy, Institute of Neuroscience and Guangxi Key Laboratory of Brain Science, School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi, P.R. China.
  • Chen X; Key Laboratory of High-Incidence-Tumour Prevention and Treatment, Guangxi Medical University, Ministry of Education, Nanning, Guangxi, P.R. China).
  • Xia L; Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, P.R. China.
  • Kong X; Key Laboratory of High-Incidence-Tumour Prevention and Treatment, Guangxi Medical University, Ministry of Education, Nanning, Guangxi, P.R. China).
  • Yin F; Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, P.R. China.
  • Liu X; Key Laboratory of High-Incidence-Tumour Prevention and Treatment, Guangxi Medical University, Ministry of Education, Nanning, Guangxi, P.R. China).
Pharm Biol ; 61(1): 839-857, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37203204
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Apoptose Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Pharm Biol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Apoptose Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Pharm Biol Ano de publicação: 2023 Tipo de documento: Article